Form 4 for DTIL PRECISION BIOSCIENCES INC
Accepted 2024-05-03 00:00:00 ET · period of report 2024-05-01 · accession 0000950170-24-053113 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-03 | 2024-05-02 | DTIL | List Alan | Chief Medical Off | S - Sale+OE | $10.32 | -290 | 4,488 | -6% | -$2,993 |
| D | 2024-05-03 | 2024-05-01 | DTIL | List Alan | Chief Medical Off | M - OptEx | — | +982 | 4,778 | +26% | — |
| D | 2024-05-03 | 2024-05-01 | DTIL | List Alan | Chief Medical Off | M - OptEx | $0.00 | -982 | 981 | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-05-02 | S | D | 290 | $10.32 | 4,488 | D | — | — | (F4) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.11 to $10.53. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the range set forth in this footnote. |
| 2 | Common | Common Stock | 2024-05-01 | M | A | 982 | — | 4,778 | D | — | — | (F1) Represents the partial vesting of Restricted Stock Units ("RSUs") on March 3, 2024, and subsequent settlement of such vested RSUs on May 1, 2024. (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. |
| 3 | Derivative | Restricted Stock Units | 2024-05-01 | M | D | 982 | $0.00 | 981 | D | — · — to — | 982 Common Stock | (F2) Each restricted stock unit represents a contingent right to receive one share of the Issuer's Common Stock. (F5) On March 3, 2022 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on March 3, 2023, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. |